Cadrenal Therapeutics, Inc. Balance Sheet
Cadrenal Therapeutics, Inc.'s total assets for Q3 2025 were $4.09M, a decrease of -31.63% from the previous quarter. CVKD total liabilities were $1.35M for the fiscal quarter, a -19.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.